申请人:SHIJIAZHUANG SAGACITY NEW DRUG DEVELOPMENT
COMPANY, LTD.
公开号:EP3753937A1
公开(公告)日:2020-12-23
Disclosed are a compound as an ATR inhibitor and an application in preparing a drug as an ATR inhibitor. In particular, disclosed is a compound represented by formula (I) or an isomer or pharmaceutically acceptable salt thereof.